TY - JOUR
T1 - Supplemental Cancer Screening for Women With Dense Breasts
T2 - Guidance for Health Care Professionals
AU - Vegunta, Suneela
AU - Kling, Juliana M.
AU - Patel, Bhavika K.
N1 - Funding Information:
We thank Sandhya Pruthi, MD, Professor, General Internal Medicine, Mayo Clinic, Rochester, Minnesota, for her valuable suggestions.
Publisher Copyright:
© 2021 Mayo Foundation for Medical Education and Research
PY - 2021/11
Y1 - 2021/11
N2 - Mammography is the standard for breast cancer screening. The sensitivity of mammography in identifying breast cancer, however, is reduced for women with dense breasts. Thirty-eight states have passed laws requiring that all women be notified of breast tissue density results in their mammogram report. The notification includes a statement that differs by state, encouraging women to discuss supplemental screening options with their health care professionals (HCPs). Several supplemental screening tests are available for women with dense breast tissue, but no established guidelines exist to direct HCPs in their recommendation of preferred supplemental screening test. Tailored screening, which takes into consideration the patient's mammographic breast density and lifetime breast cancer risk, can guide breast cancer screening strategies that are more comprehensive. This review describes the benefits and limitations of the various available supplemental screening tests to guide HCPs and patients in choosing the appropriate breast cancer screening.
AB - Mammography is the standard for breast cancer screening. The sensitivity of mammography in identifying breast cancer, however, is reduced for women with dense breasts. Thirty-eight states have passed laws requiring that all women be notified of breast tissue density results in their mammogram report. The notification includes a statement that differs by state, encouraging women to discuss supplemental screening options with their health care professionals (HCPs). Several supplemental screening tests are available for women with dense breast tissue, but no established guidelines exist to direct HCPs in their recommendation of preferred supplemental screening test. Tailored screening, which takes into consideration the patient's mammographic breast density and lifetime breast cancer risk, can guide breast cancer screening strategies that are more comprehensive. This review describes the benefits and limitations of the various available supplemental screening tests to guide HCPs and patients in choosing the appropriate breast cancer screening.
UR - http://www.scopus.com/inward/record.url?scp=85118155899&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118155899&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2021.06.001
DO - 10.1016/j.mayocp.2021.06.001
M3 - Review article
C2 - 34686363
AN - SCOPUS:85118155899
SN - 0025-6196
VL - 96
SP - 2891
EP - 2904
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 11
ER -